Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP)

Price 13.00p on 19-07-2024 at 16:30:02
Change 1.00p 8.33%
Buy 13.50p
Sell 12.50p
Buy / Sell SCLP Shares
Last Trade: Unknown 180,000.00 at 13.00p
Day's Volume: 2,907,631
Last Close: 13.00p
Open: 12.15p
ISIN: GB00B63D3314
Day's Range 12.15p - 13.40p
52wk Range: 7.65p - 17.375p
Market Capitalisation: £121m
VWAP: 12.97142p
Shares in Issue: 930m

Recent Trades History Scancell Holdings (SCLP)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 180,000 13.00p OTC Trade
16:07:29 - 19-Jul-24
Sell* 9,910 12.822p Ordinary
15:30:00 - 19-Jul-24
Buy* 3,690 13.25p Ordinary
15:26:40 - 19-Jul-24
Sell* 2,202 12.822p Ordinary
15:25:39 - 19-Jul-24
Buy* 22,692 13.22p Ordinary
15:24:21 - 19-Jul-24
Buy* 4,906 13.25p Ordinary
15:19:52 - 19-Jul-24
Buy* 4,000 13.25p Ordinary
15:18:36 - 19-Jul-24
Buy* 8,000 13.25p Ordinary
15:17:23 - 19-Jul-24
Sell* 10,000 12.822p Ordinary
15:16:38 - 19-Jul-24
Sell* 10,000 12.822p Ordinary
15:13:29 - 19-Jul-24

Share Price History for Scancell Holdings

Time period:
to
Date Open High Low Close Volume

Share News for Scancell Holdings

TRADING UPDATES: Creo extends contract; Belluscura raises funds

2nd Jul 2024 20:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Shares in Scancell climb as strikes exclusive drug evaluation deal

12th Jun 2024 13:13

(Alliance News) - Scancell Holdings PLC on Wednesday announced a major international biotechnology company will exclusively evaluate a Scancell investigational anti-glycan monoclonal antibody for development of novel therapeutic products. Read More

Scancell doses first patient in melanoma-focused trials

26th Mar 2024 14:00

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic. Read More

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

5th Feb 2024 14:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Scancell interim loss narrows amid finance gain on derivative

30th Jan 2024 13:56

(Alliance News) - Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability. Read More

FTSE 100 Latest
Value8,155.72
Change-49.17

Login to your account

Forgot Password?

Not Registered